| Original language | English (US) |
|---|---|
| Pages (from-to) | 971-972 |
| Number of pages | 2 |
| Journal | Clinical chemistry |
| Volume | 64 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2018 |
ASJC Scopus subject areas
- Clinical Biochemistry
- Biochemistry, medical
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Spherical nucleic acids : Adding a new dimension to nucleic acids and clinical chemistry. / Mirkin, Chad A.; Petrosko, Sarah Hurst.
In: Clinical chemistry, Vol. 64, No. 6, 06.2018, p. 971-972.Research output: Contribution to journal › Short survey › peer-review
TY - JOUR
T1 - Spherical nucleic acids
T2 - Adding a new dimension to nucleic acids and clinical chemistry
AU - Mirkin, Chad A.
AU - Petrosko, Sarah Hurst
N1 - Funding Information: Honoraria: C.A. Mirkin, Pfizer, Illumina. Research Funding: Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number U54CA199091. C.A. Mirkin, NIH/ NCI, U54CA199091, ACS, RSG-14-098-01-CCE, NTU-NU Nanomedicine Institute, Agmt 10/20/14, IDP Sherman Fairchild Fnd/ Lurie Cancer Center, 10043723, AFRL, FA8650-15-2v5518, NIH/ NCI, 1R01CA208783-01A, Lefkofsky Family Foundation, Agmt 30040052, DARPA, HR0011-13-2-0018, John McNicholas Pediatric Brain Tumor Foundation, JMFMAB2014. Expert Testimony: None declared. Patents: C.A. Mirkin, US Patent 9051583, Japanese Patent 5749172, Chinese Patent CN ZL201080007013.1, US Patent 9139827, Japanese Patent JP 5801205, Mexican Patent MX 332529, US Patent 9216155, Japanese Patent JP 5866119, Japanese Patent JP 5866401, Japanese Patent JP5863670, Australian Patent AU2009238607, European Patent EP 1747295, European Patent EP 181417, Germany Patent EP 2160464, Denmark Patent EP 2160464, United Kingdom Patent EP 2160464, Ireland Patent EP 2160464, Netherlands Patent EP 2160464, Switzerland Patent EP 2160464, France Patent EP 2160464, Sweden Patent EP 2160464, Japanese Patent JP 5863670, Mexican Patent MX 335381, Chinese Patent CN 200980118614.7, US Patent 9376690, Chinese Patent CN 201080058178.1, Japanese Patent JP 5866119, Australian Patent AU 2011207563, Japanese Patent, JP 5863670, Australian Patent AU 2009316286 B2, Chinese Patent ZL200880011218.X, US Patent 9506056 B2, European Patent EP 2288336, Japanese Patent JP 5866401, Australian Patent AU2010237001, South Korean Patent 10-1692880, European Patent EP 2288336, US Patent 9617541. Other Remuneration: C.A. Mirkin, Journal of the American Chemical Society, President’s Council of Advisors on Science and Technology, Exicure, Inc.
PY - 2018/6
Y1 - 2018/6
UR - http://www.scopus.com/inward/record.url?scp=85047959642&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047959642&partnerID=8YFLogxK
U2 - 10.1373/clinchem.2016.268516
DO - 10.1373/clinchem.2016.268516
M3 - Short survey
C2 - 29222341
AN - SCOPUS:85047959642
VL - 64
SP - 971
EP - 972
JO - Clinical Chemistry
JF - Clinical Chemistry
SN - 0009-9147
IS - 6
ER -